These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2531936)

  • 1. [New approaches in choosing the therapy of patients with hypertension].
    Ol'binskaia LI; Stiazhkin VIu; Iamshchikov SN
    Ter Arkh; 1989; 61(9):24-9. PubMed ID: 2531936
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of metolazone, a long-acting antihypertensive/diuretic.
    Weingarten C
    Curr Ther Res Clin Exp; 1976 Dec; 20(6):737-44. PubMed ID: 827419
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of middle-aged and elderly hypertension patients under outpatient conditions].
    Maevskiĭ AA
    Vrach Delo; 1990 Mar; (3):62-4. PubMed ID: 2368366
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment with Pharmachim's Chlophazolin of hypertension and symptomatic hypertonia].
    Koĭchev A; Belovezhdov N; Chakŭrski I; Stefanov G; Angelova I
    Vutr Boles; 1986; 25(1):72-7. PubMed ID: 2872753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of long-term treatment of patients with hypertension].
    Gurgenian SV; Mikaelian ES; Pogosian SA; Babaian AS; Arutiunian EA
    Ter Arkh; 1988; 60(2):89-92. PubMed ID: 2966992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of cardiac hypertrophy and night-time blood pressure reduction.
    Muiesan ML; Rizzoni D; Zulli R; Calebich S; Porteri E; Agabiti-Rosei E
    J Hypertens Suppl; 1993 Dec; 11(5):S300-1. PubMed ID: 8158395
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sanegyt therapy of moderately severe and severe arterial hypertension].
    Stankusheva G; Elenkova A
    Vutr Boles; 1981; 20(2):81-7. PubMed ID: 7257337
    [No Abstract]   [Full Text] [Related]  

  • 9. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prolonged administration of metolazone in the treatment of essential hypertension.
    Cangiano JL
    Curr Ther Res Clin Exp; 1976 Dec; 20(6):745-50. PubMed ID: 827420
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study on the Tolerance to Antihypertensive Medication II. Evaluation of the antihypertensive effectiveness and control of hypertension. Cooperative Group for the Study of Tolerance to Antihypertensive Medication].
    Med Clin (Barc); 1986 Nov; 87(17):703-9. PubMed ID: 3796107
    [No Abstract]   [Full Text] [Related]  

  • 12. [Arterial hypertension in middle-aged and elderly patients].
    Pomerantsev VP
    Sov Med; 1990; (12):27-30. PubMed ID: 2097755
    [No Abstract]   [Full Text] [Related]  

  • 13. Patients with essential hypertension.
    Widimský J
    Cor Vasa; 1990; 32(1):1-2. PubMed ID: 1971205
    [No Abstract]   [Full Text] [Related]  

  • 14. [After pharmacologic blood pressure treatment: only two in ten male hypertensive patients attain the recommended diastolic pressure].
    Dahlöf C; Edwall AS; Johansson E
    Lakartidningen; 1988 Jun; 85(22):1986-7. PubMed ID: 2897514
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combined antihypertensive pharmacotherapy].
    Anshelevich IuV; Raĭbaert IaIa; Dumesh SZ; Orlova VP; Itskovich VS
    Klin Med (Mosk); 1988 Aug; 66(8):65-8. PubMed ID: 3193736
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of acebutolol in arterial hypertension. Apropos of 13 records of Senegalese patients].
    Koate P; Diouf S; Sylla M; Sarr M
    Dakar Med; 1982; 27(4):547-64. PubMed ID: 7184740
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
    Kirch W; von Gizycki C
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
    [No Abstract]   [Full Text] [Related]  

  • 18. [Course of hypertension and the potentials for regression].
    Shkhvatsabaia IK
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(1):5-12. PubMed ID: 6212068
    [No Abstract]   [Full Text] [Related]  

  • 19. [Kidney function and the effectiveness of hypotensive therapy of patients with hypertension].
    Tikhonov VP; Bol'shakova RKh
    Ter Arkh; 1986; 58(8):73-6. PubMed ID: 3764766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure control in patients initiating antihypertensive therapy.
    Weycker D; Edelsberg J; Vincze G; Levy DG; Kartashov A; Oster G
    Ann Pharmacother; 2008 Feb; 42(2):169-76. PubMed ID: 18182472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.